These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14598200)

  • 1. Nandrolone Progress Report to the UK Sports Council from the Expert Committee on Nandrolone February 2003.
    Callicott R; Kicman AT;
    Int J Sports Med; 2003 Nov; 24(8):620-6. PubMed ID: 14598200
    [No Abstract]   [Full Text] [Related]  

  • 2. Urine nandrolone metabolites: false positive doping test?
    Kohler RM; Lambert MI
    Br J Sports Med; 2002 Oct; 36(5):325-9. PubMed ID: 12351328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances?
    Bricout V; Wright F
    Eur J Appl Physiol; 2004 Jun; 92(1-2):1-12. PubMed ID: 15042372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs and food supplements in sports. The nandrolone lessons.
    Benzi G; Ceci A
    Minerva Pediatr; 2001 Oct; 53(5):395-6. PubMed ID: 11668257
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P; Delbeke FT
    J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of doping in human urine by gas chromatography-high resolution mass spectrometry].
    Xing YY; Liu X; Zhang YM; Wang XB; Xu YX
    Yao Xue Xue Bao; 2012 Dec; 47(12):1667-70. PubMed ID: 23460974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference standards to underpin the detection of steroid abuse by athletes.
    Mackay LG
    Anal Bioanal Chem; 2008 Jun; 391(3):911-3. PubMed ID: 18278486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary nandrolone metabolites in antidoping control].
    Pépin G; Vayssette F; Gaillard Y
    Ann Pharm Fr; 2001 Sep; 59(5):345-9. PubMed ID: 11787429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of in vitro technologies to study phase II conjugation in equine sports drug surveillance.
    Taylor P; Scarth JP; Hillyer LL
    Bioanalysis; 2010 Dec; 2(12):1971-88. PubMed ID: 21110741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematological testing and antidoping policies - Re: Robinson N, Schattenberg L, Zorzoli M, Mangin P, Saugy M. Haematological analysis conducted at the departure of the Tour de France 2001. Int J Sports Med 2005; 26: 200-207.
    Lippi G; Franchini M; Guidi GC
    Int J Sports Med; 2005; 26(6):508-9; author reply 510-1. PubMed ID: 16037898
    [No Abstract]   [Full Text] [Related]  

  • 11. Doping: a paradigm shift has taken place in testing.
    Sottas PE; Saudan C; Saugy M
    Nature; 2008 Sep; 455(7210):166. PubMed ID: 18784700
    [No Abstract]   [Full Text] [Related]  

  • 12. Contamination of dietary supplements and positive drug tests in sport.
    Maughan RJ
    J Sports Sci; 2005 Sep; 23(9):883-9. PubMed ID: 16195040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of undeclared doping substances in nutritional supplements in the context of follow-up investigations concerning adverse analytical findings.
    Mareck U; Geyer H; Schertel T; Petring S; Krug O; Thevis M
    Drug Test Anal; 2021 Nov; 13(11-12):1911-1914. PubMed ID: 34476910
    [No Abstract]   [Full Text] [Related]  

  • 14. Preanalytical phase of soluble receptor of transferrin.
    Banfi G
    Int J Sports Med; 2007 Jan; 28(1):88-9. PubMed ID: 17203438
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possible reasons for the presence of nandrolone metabolites in urine].
    Pokrywka A; Kwiatkowska D; Gorczyca D
    Arch Med Sadowej Kryminol; 2009; 59(2):155-8. PubMed ID: 20073268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The faking of champions.
    DeFrancesco L
    Nat Biotechnol; 2004 Sep; 22(9):1069-71. PubMed ID: 15340461
    [No Abstract]   [Full Text] [Related]  

  • 17. The science of doping.
    Berry DA
    Nature; 2008 Aug; 454(7205):692-3. PubMed ID: 18685682
    [No Abstract]   [Full Text] [Related]  

  • 18. Discrimination of the nature of doping with 19-norsteroids through hair analysis.
    Kintz P; Cirimele V; Ludes B
    Clin Chem; 2000 Dec; 46(12):2020-2. PubMed ID: 11106346
    [No Abstract]   [Full Text] [Related]  

  • 19. What price the Olympian ideal?
    Abbott A
    Nature; 2000 Sep; 407(6801):124-7. PubMed ID: 11001030
    [No Abstract]   [Full Text] [Related]  

  • 20. [Norandrostenolone and noretiocholanolone: metabolite markers].
    Kintz P; Cirimele V; Ludes B
    Acta Clin Belg; 1999; 53 Suppl 1():68-73. PubMed ID: 10216987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.